Relationship of -Blocker Dose with Outcomes in Ambulatory Heart Failure Patients with Systolic Dysfunction: Results from the HF-ACTION Trial

OBJECTIVES: To examine the association between baseline beta-blocker (BB) dose and outcomes in the HF-ACTION trial. BACKGROUND: BBs reduce morbidity and mortality in chronic heart failure (HF) patients with reduced ejection fraction, but it is unclear whether titrating to higher BB doses improves ou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fiuzat, Mona, Wojdyla, Daniel, Kitzman, Dalane, Fleg, Jerome, Keteyian, Steven J., Kraus, William E., Piña, Ileana L., Whellan, David, O’Connor, Christopher M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396733/
https://ncbi.nlm.nih.gov/pubmed/22560018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.03.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados